Type 2 diabetes UK statistics: 4.9 million and rising (2026 update)
السكري من النوع 2 في المملكة المتحدة: 4.9 مليون والأرقام في ازدياد (2026)
Author: Feras Alayed - Therapeutic & Behavioral Nutrition Specialist
Published:
Category: british-health
Reading Time: 11 minutes
Key Takeaways
- Around 4.9 million people in the UK now have a recorded diagnosis of diabetes — the vast majority are type 2. ([diabetes.org.uk](https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics?gad_campaignid=15219795550&gad_source=1&gbraid=0AAAAAD4IfZVxOb_v_qcb4sxk18Myy0CSc&utm_source=openai))
- Including people with prediabetes/non‑diabetic hyperglycaemia, more than 12 million adults are affected by diabetes or elevated blood‑sugar risk markers. ([diabetes.org.uk](https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics?gad_campaignid=15219795550&gad_source=1&gbraid=0AAAAAD4IfZVxOb_v_qcb4sxk18Myy0CSc&utm_source=openai))
- Type 2 diabetes diagnoses have doubled over the last 15–20 years; demographics, obesity and socioeconomic factors drive regional differences. ([assets.publishing.service.gov.uk](https://assets.publishing.service.gov.uk/media/68d3ee72b6c608ff9421b293/health-trends-and-variation-in-England-25-september-2025.pdf?utm_source=openai))
- The Healthier You: NHS Diabetes Prevention Programme (NHS DPP) is available across England (with parallel programmes or pilots in Wales, Scotland and Northern Ireland) and can reduce progression to type 2 diabetes for people with NDH. ([england.nhs.uk](https://www.england.nhs.uk/diabetes/diabetes-prevention/?utm_source=openai))
- Lifestyle interventions — weight management, increased physical activity and structured behavioural programmes — reduce progression to type 2 diabetes; digital delivery can be effective where available. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11832527/?utm_source=openai))
TL;DR
The UK now records roughly 4.9 million people with diabetes (predominantly type 2), and combined with those at high risk the burden exceeds 12 million adults. Rising prevalence places pressure on GP services, NHS prescriptions and secondary care; prevention via the NHS Diabetes Prevention Programme and evidence‑based lifestyle measures remains the most scalable option. ([diabetes.org.uk](https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics?gad_campaignid=15219795550&gad_source=1&gbraid=0AAAAAD4IfZVxOb_v_qcb4sxk18Myy0CSc&utm_source=openai))
🇬🇧 Want to take action now? Try Feel Great → | Chat with a coach →
Type 2 Diabetes in the UK: 4.9 Million and Rising
Shocking UK statistic: Latest charity and NHS data place the number of people living with diagnosed diabetes in the UK at about 4.9 million — and when you add people with non‑diabetic hyperglycaemia (NDH/prediabetes), more than one in five adults are affected by raised blood‑sugar or diabetes risk. ([diabetes.org.uk](https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics?gad_campaignid=15219795550&gad_source=1&gbraid=0AAAAAD4IfZVxOb_v_qcb4sxk18Myy0CSc&utm_source=openai))
Why these numbers matter for the UK
Diabetes is not just about blood sugar. It is a major driver of cardiovascular disease, kidney failure, sight loss and limb amputation — conditions that create long‑term cost and demand for NHS services (GP appointments, medications on NHS prescriptions, outpatient clinics and A&E attendances for acute complications). The British Heart Foundation and NHS analyses show regional variation in prevalence, with higher rates in more deprived areas. ([bhf.org.uk](https://www.bhf.org.uk/-/media/files/for-professionals/research/heart-statistics/bhf-statistics-compendium-2025.pdf?hash=1784F6B0093D2DBA631E8E166A5BCA2D&rev=9d8068836c024cb2a0c6da81ed41c62a&utm_source=openai))
How many people, really? Understanding the figures
Key UK sources (Diabetes UK, NHS Digital/National Diabetes Audit, GOV.UK diabetes profile) report:
- Approximately 4.6–4.9 million people with a recorded diagnosis of diabetes (most recent aggregated reporting). ([diabetes.org.uk](https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics?gad_campaignid=15219795550&gad_source=1&gbraid=0AAAAAD4IfZVxOb_v_qcb4sxk18Myy0CSc&utm_source=openai))
- An estimated 6–7 million people at increased risk of type 2 diabetes (NDH/prediabetes) based on blood‑sugar markers — taking the combined figure (diabetes + prediabetes) above 12 million adults. ([diabetes.org.uk](https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics?gad_campaignid=15219795550&gad_source=1&gbraid=0AAAAAD4IfZVxOb_v_qcb4sxk18Myy0CSc&utm_source=openai))
- Numbers continue to rise: diagnoses of type 2 diabetes have approximately doubled over the last 15 years in some datasets. ([assets.publishing.service.gov.uk](https://assets.publishing.service.gov.uk/media/68d3ee72b6c608ff9421b293/health-trends-and-variation-in-England-25-september-2025.pdf?utm_source=openai))
Regional snapshot (UK nations and English regions)
Prevalence differs across regions: NHS and BHF data show diagnosed diabetes registers ranging from about 7%–8.6% in many English regions; separate reporting covers Scotland, Wales and Northern Ireland. This variation is driven by age structure, obesity rates, deprivation and ethnicity. See table below for illustrative figures from the British Heart Foundation compendium and NHS registers. ([bhf.org.uk](https://www.bhf.org.uk/-/media/files/for-professionals/research/heart-statistics/bhf-statistics-compendium-2025.pdf?hash=1784F6B0093D2DBA631E8E166A5BCA2D&rev=9d8068836c024cb2a0c6da81ed41c62a&utm_source=openai))
| Area | Approx. registered % (latest) |
|---|---|
| England (overall) | ~7.7% (c. 3.94 million on registers). ([bhf.org.uk](https://www.bhf.org.uk/-/media/files/for-professionals/research/heart-statistics/bhf-statistics-compendium-2025.pdf?hash=1784F6B0093D2DBA631E8E166A5BCA2D&rev=9d8068836c024cb2a0c6da81ed41c62a&utm_source=openai)) |
| Scotland | ~7.0% (c. 310,000). ([bhf.org.uk](https://www.bhf.org.uk/-/media/files/for-professionals/research/heart-statistics/bhf-statistics-compendium-2025.pdf?hash=1784F6B0093D2DBA631E8E166A5BCA2D&rev=9d8068836c024cb2a0c6da81ed41c62a&utm_source=openai)) |
| Wales | ~8.2% (c. 223,000). ([bhf.org.uk](https://www.bhf.org.uk/-/media/files/for-professionals/research/heart-statistics/bhf-statistics-compendium-2025.pdf?hash=1784F6B0093D2DBA631E8E166A5BCA2D&rev=9d8068836c024cb2a0c6da81ed41c62a&utm_source=openai)) |
| Northern Ireland | ~7.0% (c. 115,000). ([bhf.org.uk](https://www.bhf.org.uk/-/media/files/for-professionals/research/heart-statistics/bhf-statistics-compendium-2025.pdf?hash=1784F6B0093D2DBA631E8E166A5BCA2D&rev=9d8068836c024cb2a0c6da81ed41c62a&utm_source=openai)) |
What counts as high blood sugar in the UK? (Key diagnostic thresholds)
UK guidance uses HbA1c and plasma glucose values; common thresholds are:
- HbA1c ≥ 48 mmol/mol (≥6.5%) — diagnostic of diabetes. ([nice.org.uk](https://www.nice.org.uk/guidance/ph38/chapter/recommendations?utm_source=openai))
- HbA1c 42–47 mmol/mol (6.0–6.4%) — often used to define non‑diabetic hyperglycaemia/prediabetes and eligibility to prevention programmes. ([nice.org.uk](https://www.nice.org.uk/guidance/ph38/chapter/recommendations?utm_source=openai))
- Fasting plasma glucose ≥7.0 mmol/L — diagnostic of diabetes; impaired fasting glucose typically 6.1–6.9 mmol/L depending on guideline and test. ([nice.org.uk](https://www.nice.org.uk/guidance/ph38/chapter/recommendations?utm_source=openai))
Who is most at risk?
Risk factors for type 2 diabetes include:
- Overweight and obesity (higher BMI and abdominal fat)
- Age — risk increases with age (many but not all cases occur in middle/older age)
- Family history and ethnicity (South Asian, Black African/Caribbean groups at higher risk)
- Physical inactivity and poor diet
- Socioeconomic deprivation and regionally concentrated risk. ([bhf.org.uk](https://www.bhf.org.uk/-/media/files/for-professionals/research/heart-statistics/bhf-statistics-compendium-2025.pdf?hash=1784F6B0093D2DBA631E8E166A5BCA2D&rev=9d8068836c024cb2a0c6da81ed41c62a&utm_source=openai))
What the evidence says about prevention
High‑quality trials and systematic reviews consistently show that structured lifestyle programmes that combine weight loss, dietary change and physical activity reduce progression to type 2 diabetes in people with raised blood sugar (NDH or impaired glucose tolerance). The landmark Diabetes Prevention Program (DPP) randomised trial (NEJM) found a 58% relative risk reduction with an intensive lifestyle intervention; many translational studies and reviews show similar directions of effect when programmes are adapted for routine care. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11832527/?utm_source=openai))
Recent component network meta‑analysis and systematic reviews exploring delivery methods (face‑to‑face vs digital vs mixed models) suggest that both traditional group programmes and well‑designed digital interventions can be effective — which underpins current NHS DPP delivery options. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/39418787/?utm_source=openai))
How the NHS is responding
Key NHS actions:
- Primary care identification and referral via GP checks (including NHS Health Check) and QOF registers. ([healthcheck.nhs.uk](https://www.healthcheck.nhs.uk/commissioners-and-providers/delivery/healthier-you-nhs-diabetes-prevention-programme/?utm_source=openai))
- Healthier You: NHS Diabetes Prevention Programme (NHS DPP) — nine‑month evidence‑based behavioural programmes delivered face‑to‑face or digitally across England; pilots/analogous services operate in Wales, Scotland and Northern Ireland. Over two million referrals and nearly one million programme starts have been recorded in recent reporting. ([england.nhs.uk](https://www.england.nhs.uk/diabetes/diabetes-prevention/resources/provider-contact-details/?utm_source=openai))
- National Diabetes Audit and NICE guidelines (NG28, PH38) guide clinical care, screening and management. ([digital.nhs.uk](https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/report-1-cp-and-tt-data-release-2024-25/nda-report-1-cp-and-tt-data-release-2024-25?utm_source=openai))
What patients and the public should know (practical actions)
Practical, evidence‑based steps that may help reduce risk or improve metabolic health:
- Ask your GP for an NHS Health Check if you’re aged 40–74 or ask for an HbA1c/FPG test if you have risk factors. Referral to NHS DPP may follow a high risk result. ([england.nhs.uk](https://www.england.nhs.uk/diabetes/diabetes-prevention/?utm_source=openai))
- Aim for modest sustained weight loss where appropriate — even 5–10% of body weight can lower risk. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11832527/?utm_source=openai))
- Increase physical activity progressively toward 150 minutes of moderate activity per week and reduce prolonged sitting. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC1282458/?utm_source=openai))
- Follow structured behaviour change programmes (NHS DPP or equivalent local services) — digital options may be suitable if face‑to‑face is not available. ([england.nhs.uk](https://www.england.nhs.uk/diabetes/diabetes-prevention/resources/provider-contact-details/?utm_source=openai))
- If you take medicines or have established diabetes, keep regular GP/NHS clinic reviews; do not change medicines or fasting plans without clinical supervision (A&E is for emergencies). ([nice.org.uk](https://www.nice.org.uk/guidance/ph38/chapter/recommendations?utm_source=openai))
Evidence highlights (selected international studies)
- Diabetes Prevention Program (DPP), NEJM — intensive lifestyle intervention reduced diabetes incidence by 58% vs placebo. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11832527/?utm_source=openai))
- Component systematic reviews and network meta‑analysis (2022–2024) show delivery features (intensity, behaviour change techniques, digital tools) influence effectiveness. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/39418787/?utm_source=openai))
- Systematic reviews on combined healthy lifestyle behaviours show dose‑response reductions in type 2 diabetes risk across cohort studies. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10020027/?utm_source=openai))
- Time‑restricted eating and intermittent fasting have mixed but promising metabolic signals in RCTs and reviews; outcomes often mirror calorie restriction effects and require individual tailoring. ([journals.physiology.org](https://journals.physiology.org/doi/full/10.1152/physrev.00006.2022?doi=10.1152%2Fphysrev.00006.2022&utm_source=openai))
- GLP‑1 receptor agonist trials (semaglutide and others) show metabolic and weight‑loss effects in recent trials; these medicines are prescribed where clinically indicated under NHS pathways and NICE technology appraisals — they are not a universal prevention solution. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC12001787/?utm_source=openai))
How “Feel Great” fits in (practical, non‑medical support)
For readers exploring lifestyle‑first options, the Feel Great system is a structured lifestyle support package designed to be used alongside NHS care and self‑management (not as a medication). Elements that users report as relevant to metabolic health include:
- Balance: a soluble fibre matrix intended to blunt post‑meal glucose rises and support satiety — this may help people manage post‑prandial glucose excursions when combined with diet and activity (not a treatment).
- Unimate: yerba mate extract containing chlorogenic acids and natural polyphenols that some studies link to energy metabolism and alertness; users describe improved focus during behaviour change programmes.
- 4‑4‑12 intermittent fasting protocol: a time‑restricted eating pattern that some people find easier to follow than continuous calorie restriction; intermittent fasting trials show mixed but promising effects on weight and glycaemic markers and must be used carefully with medical review if on glucose‑lowering medicines. ([journals.physiology.org](https://journals.physiology.org/doi/full/10.1152/physrev.00006.2022?doi=10.1152%2Fphysrev.00006.2022&utm_source=openai))
- Packaging of habits and coaching: Feel Great is framed as a lifestyle support system with behaviour tools and references to clinical evidence; not a substitute for GP care or NHS prescriptions. The product literature cites >50 clinical studies in its PDR listing for ingredient profiles (review before use).
Important: always discuss any dietary supplements, structured fasting plans or medication changes with your GP or diabetes care team — especially if you take insulin, sulfonylureas, or other glucose‑lowering therapies where hypoglycaemia risk exists. ([nice.org.uk](https://www.nice.org.uk/guidance/ph38/chapter/recommendations?utm_source=openai))
People also ask
- How many people in the UK have type 2 diabetes? — About 4.6–4.9 million have a recorded diabetes diagnosis; the majority are type 2. ([diabetes.org.uk](https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics?gad_campaignid=15219795550&gad_source=1&gbraid=0AAAAAD4IfZVxOb_v_qcb4sxk18Myy0CSc&utm_source=openai))
- What is the NHS Diabetes Prevention Programme? — A nine‑month behavioural programme (face‑to‑face or digital) for people with NDH/prediabetes, delivered across England with similar efforts in other UK nations. ([england.nhs.uk](https://www.england.nhs.uk/diabetes/diabetes-prevention/?utm_source=openai))
- What blood sugar levels define prediabetes in the UK? — HbA1c 42–47 mmol/mol is commonly used to define NDH/prediabetes. ([nice.org.uk](https://www.nice.org.uk/guidance/ph38/chapter/recommendations?utm_source=openai))
- Can lifestyle change really reduce risk? — Yes: intensive, structured programmes reduce progression to type 2 diabetes in high‑risk people. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11832527/?utm_source=openai))
- Should I try intermittent fasting? — It may help some people with weight and metabolic markers, but should be discussed with your GP if you take diabetes medicines. ([journals.physiology.org](https://journals.physiology.org/doi/full/10.1152/physrev.00006.2022?doi=10.1152%2Fphysrev.00006.2022&utm_source=openai))
Frequently asked questions (FAQ)
- Is type 2 diabetes reversible? Some people achieve remission of type 2 diabetes through substantial, sustained weight loss and metabolic changes; remission is defined clinically and should be supervised by NHS clinicians. Lifestyle change can produce remission in selected cases but is not guaranteed. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11832527/?utm_source=openai))
- What should my HbA1c be? Individual targets vary. HbA1c <48 mmol/mol is below the diagnostic threshold for diabetes; people with diabetes often have personalised targets agreed with their clinical team. Consult your GP or diabetes nurse. ([nice.org.uk](https://www.nice.org.uk/guidance/ph38/chapter/recommendations?utm_source=openai))
- How do I get onto the NHS DPP? Ask your GP for an HbA1c or risk assessment; if eligible you may be referred from primary care, the NHS Health Check, or self‑referral routes where available. ([england.nhs.uk](https://www.england.nhs.uk/diabetes/diabetes-prevention/?utm_source=openai))
- Are digital prevention programmes as good as face‑to‑face? High‑quality digital programmes can approach the effectiveness of face‑to‑face programmes for some outcomes, depending on design and engagement. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/39418787/?utm_source=openai))
- Can supplements or products prevent diabetes? No single supplement prevents diabetes. Some ingredients (for example soluble fibre) may help with post‑meal glucose when used with healthy diet and activity, but supplements are adjuncts — not substitutes for evidence‑based lifestyle programmes or clinical care. Always check with your GP.
Practical next steps (if you are worried)
- Make an appointment with your GP or practice nurse; request an HbA1c/FPG if you have risk factors. ([nhs.uk](https://www.nhs.uk/conditions/type-2-diabetes/treatment/?utm_source=openai))
- Ask about referral to the Healthier You NHS DPP (or local equivalent in Scotland, Wales, Northern Ireland). ([england.nhs.uk](https://www.england.nhs.uk/diabetes/diabetes-prevention/resources/provider-contact-details/?utm_source=openai))
- Consider starting a structured, evidence‑based behaviour change plan: small, sustainable changes beat short intense diets for long‑term risk reduction. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11832527/?utm_source=openai))
- If considering intermittent fasting, supplements or GLP‑1 medicines, discuss benefits, risks and NHS eligibility with your clinician first. ([journals.physiology.org](https://journals.physiology.org/doi/full/10.1152/physrev.00006.2022?doi=10.1152%2Fphysrev.00006.2022&utm_source=openai))
References & Scientific Sources
- Diabetes UK. Diabetes prevalence and statistics (latest pages). ([diabetes.org.uk](https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics?gad_campaignid=15219795550&gad_source=1&gbraid=0AAAAAD4IfZVxOb_v_qcb4sxk18Myy0CSc&utm_source=openai))
- GOV.UK. Diabetes profile: statistical commentary, April 2026. ([gov.uk](https://www.gov.uk/government/statistics/diabetes-profile-update-april-2026?utm_source=openai))
- NHS Digital / National Diabetes Audit (2024–25 data). ([digital.nhs.uk](https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/report-1-cp-and-tt-data-release-2024-25/nda-report-1-cp-and-tt-data-release-2024-25?utm_source=openai))
- NHS England. Healthier You: NHS Diabetes Prevention Programme (NHS DPP) information and delivery details. ([england.nhs.uk](https://www.england.nhs.uk/diabetes/diabetes-prevention/?utm_source=openai))
- NICE. Type 2 diabetes in adults: management (NG28) and prevention in people at high risk (PH38). ([nice.org.uk](https://www.nice.org.uk/guidance/ng28?UID=48952071320252240212&utm_source=openai))
- British Heart Foundation. Heart statistics compendium (diabetes prevalence by region). ([bhf.org.uk](https://www.bhf.org.uk/-/media/files/for-professionals/research/heart-statistics/bhf-statistics-compendium-2025.pdf?hash=1784F6B0093D2DBA631E8E166A5BCA2D&rev=9d8068836c024cb2a0c6da81ed41c62a&utm_source=openai))
- Knowler WC et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. NEJM 2002. (Seminal RCT). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11832527/?utm_source=openai))
- Systematic review & component network meta‑analysis of non‑pharmacological diabetes prevention programmes (2022–2024). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/39418787/?utm_source=openai))
- Physiological Reviews. Complex physiology and clinical implications of time‑restricted eating (2022). ([journals.physiology.org](https://journals.physiology.org/doi/full/10.1152/physrev.00006.2022?doi=10.1152%2Fphysrev.00006.2022&utm_source=openai))
- Semaglutide and GLP‑1 clinical trial meta‑analyses and STEP/SUSTAIN programme publications (selected). ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC12001787/?utm_source=openai))
Medical disclaimer
This article is informational and written for a UK audience. It does not replace one‑to‑one medical advice from your GP, diabetes specialist or other qualified clinician. If you have concerns about symptoms, blood sugar readings, medications or planned fasting or supplement use, speak to your GP or NHS diabetes care team. In an emergency (severe hypoglycaemia, diabetic ketoacidosis, chest pain, breathlessness) attend A&E or call 999.
🇬🇧 Ready to Start Your Health Transformation?
Join thousands across United Kingdom who have improved their metabolic health with the Feel Great system. Backed by 50+ clinical studies and listed in the Physicians' Desk Reference (PDR).
✅ Free Delivery Across England, Scotland, Wales & Northern Ireland | 90-Day Money-Back Guarantee
النقاط الرئيسية
- يوجد حوالى 4.9 مليون شخص في المملكة المتحدة مسـجل لديهم مرض السكري — الغالبية من النوع 2. ([diabetes.org.uk](https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics?gad_campaignid=15219795550&gad_source=1&gbraid=0AAAAAD4IfZVxOb_v_qcb4sxk18Myy0CSc&utm_source=openai))
- بإضافة الأشخاص ذوي فرط سكر الدم غير السكري (المعروف بـNDH أو مرحلة ما قبل السكري)، يتجاوز عدد البالغين المتأثرين 12 مليوناً. ([diabetes.org.uk](https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics?gad_campaignid=15219795550&gad_source=1&gbraid=0AAAAAD4IfZVxOb_v_qcb4sxk18Myy0CSc&utm_source=openai))
- تشهد حالات السكري من النوع 2 ارتفاعاً ملحوظاً عبر السنوات، مع تفاوت إقليمي مرتبط بالبدانة والفوارق الاجتماعية والاقتصادية. ([assets.publishing.service.gov.uk](https://assets.publishing.service.gov.uk/media/68d3ee72b6c608ff9421b293/health-trends-and-variation-in-England-25-september-2025.pdf?utm_source=openai))
- برنامج Healthier You (NHS Diabetes Prevention Programme) متاح عبر إنجلترا وتوجد مبادرات مماثلة في أسكلتند، ويلز وأيرلندا الشمالية؛ إكمال البرنامج يقلل من خطر التطور إلى السكري. ([england.nhs.uk](https://www.england.nhs.uk/diabetes/diabetes-prevention/?utm_source=openai))
- تدخلات تغيير نمط الحياة المهيكلة والرقمية يمكن أن تقلل خطر الإصابة — وهنالك أدلة عالية الجودة على ذلك من تجارب ومراجعات منهجية. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11832527/?utm_source=openai))
الملخص المختصر
حوالي 4.9 مليون شخص في المملكة المتحدة لديهم تشخيص مسجل للسكري (معظمهم نوع 2)، ومع الأشخاص ذوي مخاطر ارتفاع سكر الدم يتجاوز العبء 12 مليون بالغ. هذا يشكل ضغوطاً متصاعدة على خدمات GP، وصفات NHS، والرعاية الثانوية. يوفر NHS برنامج وقائي وطنـي وطرق علاجية وإدارية مستندة إلى إرشادات NICE. ([diabetes.org.uk](https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics?gad_campaignid=15219795550&gad_source=1&gbraid=0AAAAAD4IfZVxOb_v_qcb4sxk18Myy0CSc&utm_source=openai))
🇬🇧 هل تريد اتخاذ خطوة الآن؟ جرب Feel Great ← | تحدث مع مدرب ←
السكري من النوع 2 في المملكة المتحدة: 4.9 مليون والأرقام في ازدياد
إحصائية صادمة للمملكة المتحدة: تظهر تقارير الجمعيات الخيرية ودلائل NHS أن عدد الأشخاص المسجلين لديهم مرض السكري يقدر بحوالى 4.9 مليون، وإذا أُضيف أولئك الذين لديهم فرط سكر الدم غير السكري يصبح أكثر من واحد من كل خمسة بالغين متأثراً بارتفاع سكر الدم أو خطره. ([diabetes.org.uk](https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics?gad_campaignid=15219795550&gad_source=1&gbraid=0AAAAAD4IfZVxOb_v_qcb4sxk18Myy0CSc&utm_source=openai))
لماذا هذه الأرقام مهمة؟
السكري يزيد مخاطر أمراض القلب والأوعية الدموية، فشل الكُلى، فقدان النظر وبتر الأطراف — وكلها حالات تتطلب موارد طويلة المدى من NHS (زيارات GP، وصفات طبية، عيادات خارجية وحالات طارئة). تُظهر بيانات British Heart Foundation تفاوتاً إقليمياً يعكس الفوارق في البدانة والحرمان الاجتماعي. ([bhf.org.uk](https://www.bhf.org.uk/-/media/files/for-professionals/research/heart-statistics/bhf-statistics-compendium-2025.pdf?hash=1784F6B0093D2DBA631E8E166A5BCA2D&rev=9d8068836c024cb2a0c6da81ed41c62a&utm_source=openai))
فهم الأرقام
- حوالي 4.6–4.9 مليون شخص لديهم تشخيص مسجل للسكري في المملكة المتحدة (المعظم نوع 2). ([diabetes.org.uk](https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics?gad_campaignid=15219795550&gad_source=1&gbraid=0AAAAAD4IfZVxOb_v_qcb4sxk18Myy0CSc&utm_source=openai))
- حوالي 6–7 مليون شخص معرضون للخطر (NDH / مرحلة ما قبل السكري) مما يجعل المجموع أكبر من 12 مليون بالغ. ([diabetes.org.uk](https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics?gad_campaignid=15219795550&gad_source=1&gbraid=0AAAAAD4IfZVxOb_v_qcb4sxk18Myy0CSc&utm_source=openai))
- العدد في تزايد: حالات التشخيص بالنوع 2 تضاعفت خلال 15–20 سنة في بعض البيانات. ([assets.publishing.service.gov.uk](https://assets.publishing.service.gov.uk/media/68d3ee72b6c608ff9421b293/health-trends-and-variation-in-England-25-september-2025.pdf?utm_source=openai))
عُتبة التشخيص الأساسية في المملكة المتحدة
- HbA1c ≥ 48 mmol/mol (≥6.5%): دليل تشخيص السكري. ([nice.org.uk](https://www.nice.org.uk/guidance/ph38/chapter/recommendations?utm_source=openai))
- HbA1c 42–47 mmol/mol (6.0–6.4%): عادة ما تُستخدم لتحديد NDH/مرحلة ما قبل السكري. ([nice.org.uk](https://www.nice.org.uk/guidance/ph38/chapter/recommendations?utm_source=openai))
- صيام بلازما الجلوكوز ≥7.0 mmol/L: تشخيص السكري؛ صيام 6.1–6.9 mmol/L قد يشير إلى اختلال صومى. ([nice.org.uk](https://www.nice.org.uk/guidance/ph38/chapter/recommendations?utm_source=openai))
من الأكثر عرضة؟
العوامل: السمنة، الكبر في السن، التاريخ العائلي، بعض الخلفيات الإثنية (جنوب آسيا، أفريقيا/الكاريبي)، قلة النشاط، والحرمان الاجتماعي. ([bhf.org.uk](https://www.bhf.org.uk/-/media/files/for-professionals/research/heart-statistics/bhf-statistics-compendium-2025.pdf?hash=1784F6B0093D2DBA631E8E166A5BCA2D&rev=9d8068836c024cb2a0c6da81ed41c62a&utm_source=openai))
الدليل على الوقاية
التجارب الكبرى والمراجعات أظهرت أن البرامج المنظمة التي تدمج خسارة الوزن، تغذية محسوبة ونشاط بدني تقلل من تحول مرحلة ما قبل السكري إلى السكري؛ تجربة DPP (NEJM) أظهرت خفضاً نسبياً قدره 58% مع تدخل نمط حياة مكثف. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11832527/?utm_source=openai))
ماذا يفعل NHS؟
- الكشف في الرعاية الأولية وإحالة برنامج Healthier You: NHS DPP. ([healthcheck.nhs.uk](https://www.healthcheck.nhs.uk/commissioners-and-providers/delivery/healthier-you-nhs-diabetes-prevention-programme/?utm_source=openai))
- تطبيق إرشادات NICE وإجراء تدقيق وطني (National Diabetes Audit). ([nice.org.uk](https://www.nice.org.uk/guidance/ph38/chapter/recommendations?utm_source=openai))
خطوات عملية
- اطلب فحص HbA1c/صيام من GP إذا كان لديك عوامل خطر.
- اسأل عن إحالة إلى NHS DPP أو خدمات محلية مماثلة.
- تابع تغييرات سلوكية مستدامة: نشاط رسول، تحسينات في النظام الغذائي، خسارة وزن متدرجة.
- راجع GP قبل الشروع في صوم متقطع أو إيقاف أدوية أو بدء مكملات. ([journals.physiology.org](https://journals.physiology.org/doi/full/10.1152/physrev.00006.2022?doi=10.1152%2Fphysrev.00006.2022&utm_source=openai))
كيف يتماشى "Feel Great" مع الصحة الأيضية (دون مزاعم علاجية)
Feel Great هو نظام دعم نمط حياة يتضمن عناصر مثل Balance (ألياف ذائبة)، Unimate (مستخلص يربا ماتيه)، وبروتوكول 4‑4‑12 للصوم المتقطع. قد تكون هذه الأدوات مفيدة كأجزاء من خطة سلوكية أوسع تعمل جنباً إلى جنب مع برامج مثل NHS DPP — لكنها ليست دواءً ولا بد أن تُستخدم بعد مناقشة طبية مع مقدم الرعاية الخاص بك. ([journals.physiology.org](https://journals.physiology.org/doi/full/10.1152/physrev.00006.2022?doi=10.1152%2Fphysrev.00006.2022&utm_source=openai))
مراجع مختارة
- Diabetes UK — إحصاءات عن السكري في المملكة المتحدة. ([diabetes.org.uk](https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics?gad_campaignid=15219795550&gad_source=1&gbraid=0AAAAAD4IfZVxOb_v_qcb4sxk18Myy0CSc&utm_source=openai))
- GOV.UK — Diabetes profile update April 2026. ([gov.uk](https://www.gov.uk/government/statistics/diabetes-profile-update-april-2026?utm_source=openai))
- NHS National Diabetes Audit 2024–25. ([digital.nhs.uk](https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/report-1-cp-and-tt-data-release-2024-25/nda-report-1-cp-and-tt-data-release-2024-25?utm_source=openai))
- NHS England — Healthier You: NHS Diabetes Prevention Programme. ([england.nhs.uk](https://www.england.nhs.uk/diabetes/diabetes-prevention/?utm_source=openai))
- NICE — Type 2 diabetes guidelines (NG28, PH38). ([nice.org.uk](https://www.nice.org.uk/guidance/ng28?UID=48952071320252240212&utm_source=openai))
- Knowler WC et al., NEJM (DPP trial). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11832527/?utm_source=openai))
- Systematic reviews on DPP delivery and lifestyle prevention (component network meta‑analysis). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/39418787/?utm_source=openai))
- Physiological Reviews — time‑restricted eating (2022). ([journals.physiology.org](https://journals.physiology.org/doi/full/10.1152/physrev.00006.2022?doi=10.1152%2Fphysrev.00006.2022&utm_source=openai))
تنبيه طبي
المعلومات أعلاه للمعلومات العامة ولا تغني عن استشارة طبية فردية. تحدث مع GP أو فريق السكري قبل تغيير الأدوية أو البدء بخطط صيام أو مكملات. في حالة الطوارئ (هبوط شديد في سكر الدم، غيبوبة، ألم صدر، ضيق نفس) اتصل بـ999 أو تَوجَّه إلى A&E.
🇬🇧 هل أنت مستعد لبدء تحولك الصحي؟
انضم لآلاف الأشخاص في بريطانيا الذين حسّنوا صحتهم الأيضية مع نظام Feel Great. مدعوم بأكثر من 50 دراسة سريرية.
Frequently Asked Questions
How many people in the UK have type 2 diabetes?
About 4.6–4.9 million people have a recorded diagnosis of diabetes in the UK, most of whom have type 2 diabetes. ([diabetes.org.uk](https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics?gad_campaignid=15219795550&gad_source=1&gbraid=0AAAAAD4IfZVxOb_v_qcb4sxk18Myy0CSc&utm_source=openai))
What blood sugar levels define prediabetes in the UK?
In the UK, non‑diabetic hyperglycaemia (prediabetes) is commonly defined as HbA1c 42–47 mmol/mol (6.0–6.4%); diabetes is HbA1c ≥48 mmol/mol. ([nice.org.uk](https://www.nice.org.uk/guidance/ph38/chapter/recommendations?utm_source=openai))
What is the NHS Diabetes Prevention Programme (NHS DPP)?
The Healthier You NHS DPP is a nine‑month evidence‑based lifestyle behaviour change programme (face‑to‑face or digital) for adults at high risk of developing type 2 diabetes in England; similar schemes or pilots run in other UK nations. ([england.nhs.uk](https://www.england.nhs.uk/diabetes/diabetes-prevention/?utm_source=openai))
Can lifestyle change prevent type 2 diabetes?
High‑quality trials and systematic reviews show structured lifestyle programmes can substantially reduce progression to type 2 diabetes in high‑risk people; individual results vary. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11832527/?utm_source=openai))
Should I try intermittent fasting to lower my diabetes risk?
Intermittent fasting/time‑restricted eating shows mixed but promising effects on weight and metabolic markers in recent trials. Discuss with your GP before attempting fasting if you take diabetes medicines. ([journals.physiology.org](https://journals.physiology.org/doi/full/10.1152/physrev.00006.2022?doi=10.1152%2Fphysrev.00006.2022&utm_source=openai))